Stress cardiomyopathy: Difference between revisions
Hamid Parsa (talk | contribs) |
|||
| (8 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Infobox_Disease | {{Infobox_Disease | ||
| Name = {{PAGENAME}} | | Name = {{PAGENAME}} | ||
| Line 16: | Line 15: | ||
}} | }} | ||
{{Stress cardiomyopathy}} | {{Stress cardiomyopathy}} | ||
{{CMG}} | {{CMG}}; {{AE}}{{DN}} {{AKK}} | ||
{{SK}} Takotsubo cardiomyopathy; Tako-tsubo syndrome; left ventricular apical ballooning syndrome; ampulla-shaped cardiomyopathy; broken heart syndrome; transient apical dysfunction | {{SK}} Takotsubo cardiomyopathy; Tako-tsubo syndrome; left ventricular apical ballooning syndrome; LVABS; ampulla-shaped cardiomyopathy; broken heart syndrome; transient apical dysfunction; stress-induced cardiomyopathy; SIC | ||
== [[Stress cardiomyopathy overview|Overview]] == | == [[Stress cardiomyopathy overview|Overview]] == | ||
==[[ Stress cardiomyopathy historical perspective| Historical Perspective]]== | ==[[ Stress cardiomyopathy historical perspective| Historical Perspective]]== | ||
| Line 41: | Line 40: | ||
== Treatment == | == Treatment == | ||
[[Stress cardiomyopathy medical therapy|Medical Therapy]] | [[Stress cardiomyopathy surgery|Surgery]] | [[Stress cardiomyopathy primary prevention|Primary Prevention]] | [[Stress cardiomyopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Stress cardiomyopathy future or investigational therapies|Future or Investigational Therapies]] | [[Stress cardiomyopathy medical therapy|Medical Therapy]] | [[Stress cardiomyopathy surgery|Surgery]] | [[Stress cardiomyopathy primary prevention|Primary Prevention]] | [[Stress cardiomyopathy secondary prevention|Secondary Prevention]] | [[Stress cardiomyopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Stress cardiomyopathy future or investigational therapies|Future or Investigational Therapies]] | ||
== Case Studies == | == Case Studies == | ||
| Line 47: | Line 46: | ||
: [[Stress cardiomyopathy case study one|Case #1]] | : [[Stress cardiomyopathy case study one|Case #1]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 16:29, 14 July 2020
| Stress cardiomyopathy | |
 | |
|---|---|
| Schematic representation of Takotsubo cardiomyopathy (A) compared to the situation in a normal person (B). | |
| ICD-9 | 429.83 |
| DiseasesDB | 33976 |
| MeSH | 054549 |
|
Stress cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy |
|
Case Studies |
|
Stress cardiomyopathy On the Web |
|
American Roentgen Ray Society Images of Stress cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2] Arzu Kalayci, M.D. [3]
Synonyms and keywords: Takotsubo cardiomyopathy; Tako-tsubo syndrome; left ventricular apical ballooning syndrome; LVABS; ampulla-shaped cardiomyopathy; broken heart syndrome; transient apical dysfunction; stress-induced cardiomyopathy; SIC
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Stress Cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies